Transarterial Therapies for Hepatocellular Carcinoma

被引：5
|
作者：
Makramalla, Abouelmagd [1 ]
Itri, Jason N. [1 ]
Choe, Kyuran Ann [1 ]
Ristagno, Ross L. [1 ]
机构：
[1] Univ Cincinnati, Med Ctr, Dept Radiol, UC Hlth, 234 Goodman St,ML 0761, Cincinnati, OH 45267 USA
来源：
SEMINARS IN ROENTGENOLOGY | 2016年 / 51卷 / 02期
关键词：
MR-IMAGING DIAGNOSIS; DRUG-ELUTING BEADS; PROGNOSTIC-FACTORS; CHEMOEMBOLIZATION; RADIOEMBOLIZATION; LIVER; SURVIVAL; CT; REDUCTION; EFFICACY;
D O I：
10.1053/j.ro.2016.02.005
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
[No abstract available]
引用
收藏
页码：95 / 105
页数：11
相关论文
共 50 条
  • [21] TRANSARTERIAL CHEMOEMBOLIZATION FOR HEPATOCELLULAR CARCINOMA
    Vremera, Teodora
    MEDICAL-SURGICAL JOURNAL-REVISTA MEDICO-CHIRURGICALA, 2013, 117 (01): : 182 - 182
  • [22] Curative therapies are superior to standard of care (transarterial chemoembolization) for intermediate stage hepatocellular carcinoma
    Pecorelli, Anna
    Lenzi, Barbara
    Gramenzi, Annagiulia
    Garuti, Francesca
    Farinati, Fabio
    Giannini, Edoardo G.
    Ciccarese, Francesca
    Piscaglia, Fabio
    Rapaccini, Gian Lodovico
    Di Marco, Maria
    Caturelli, Eugenio
    Zoli, Marco
    Borzio, Franco
    Sacco, Rodolfo
    Cabibbo, Giuseppe
    Felder, Martina
    Morisco, Filomena
    Gasbarrini, Antonio
    Baroni, Gianluca Svegliati
    Foschi, Francesco G.
    Biasini, Elisabetta
    Masotto, Alberto
    Virdone, Roberto
    Bernardi, Mauro
    Trevisani, Franco
    LIVER INTERNATIONAL, 2017, 37 (03) : 423 - 433
  • [23] FOLLOW UP OF SERIAL TRANSARTERIAL CHEMOEMBOLISATION THERAPIES FOR HEPATOCELLULAR CARCINOMA OVER 3 YEARS
    Suthaharan, Ms Kajanthini
    Pembroke, Tom
    GUT, 2022, 71 : A16 - A17
  • [24] Combination therapies plus transarterial chemoembolization in hepatocellular carcinoma: a snapshot of clinical trial progress
    Brown, Zachary J.
    Hewitt, D. Brock
    Pawlik, Timothy M.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2022, 31 (04) : 379 - 391
  • [25] GALAD score correlates with therapy response for transarterial and systemic therapies in patients with hepatocellular carcinoma
    Olbrich, Anne
    Niemeyer, Johannes
    Seifert, Hendrik
    Gros, Olga
    Lordick, Florian
    Forstmeyer, Dirk
    Seehofer, Daniel
    Sucher, Robert
    Rademacher, Sebastian
    Denecke, Timm
    Ebel, Sebastian
    Linder, Nicolas
    Matz-Soja, Madlen
    Berg, Thomas
    van Boemmel, Florian
    JOURNAL OF HEPATOLOGY, 2022, 77 : S383 - S384
  • [26] Preoperative Transarterial Chemoembolization for Hepatocellular Carcinoma
    Kishi, Yoji
    Saiura, Akio
    Yamamoto, Junji
    Koga, Rintaro
    Seki, Makoto
    Morimura, Ryo
    Yoshioka, Ryuji
    Kokudo, Norihiro
    Yamaguchi, Toshiharu
    HEPATO-GASTROENTEROLOGY, 2012, 59 (119) : 2295 - 2299
  • [27] Racial and Ethnic Disparities among Participants in Hepatocellular Carcinoma Clinical Studies Evaluating Transarterial Therapies
    Garg, Tushar
    Gong, Anna J.
    Khalil, Adham
    Gowda, Prateek C.
    Weinstein, Robert M.
    Holly, Brian P.
    Weiss, Clifford R.
    JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2023, 34 (01) : 4 - +
  • [28] Preresection transarterial chemoembolization for hepatocellular carcinoma
    Sim Sai Tin
    Viroj Wiwanitkit
    Indian Journal of Gastroenterology, 2015, 34 (2) : 188 - 188
  • [29] Sorafenib versus transarterial chemoembolization as adjuvant therapies for patients with hepatocellular carcinoma and microvascular invasion.
    Bi, Xinyu
    Gao, Jie
    Cai, Jianqiang
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [30] Transarterial ablative therapy of hepatocellular carcinoma
    Mahnken, A. H.
    RADIOLOGE, 2014, 54 (07): : 685 - 693
12345